Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert-Jan Creemers

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Drugs & Aging|March 17, 2007
First-line treatment strategies for elderly patients with metastatic colorectal cancerHielke J Meulenbeld, Geert-Jan Creemers
Case Reports in Oncology|November 29, 2018
Capecitabine-Associated Terminal IleitisIrene E G van Hellemond, Annemarie M Thijs, Geert-Jan Creemers
Clinical Colorectal Cancer|October 14, 2021
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD DeficiencyJeroen F Schouten, Jeroen Willems, Stefan J W J Sanders, et al.
United European Gastroenterology Journal|December 17, 2019
Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practiceLaura M Legué, Nienke Bernards, Valery Epp Lemmens, et al.
Journal of Palliative Medicine|February 27, 2013
Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registryOlga Husson, Melissa S Y Thong, Floortje Mols, et al.
Clinical Colorectal Cancer|January 7, 2019
Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma PeritoneiLaura M Legué, Geert-Jan Creemers, Ignace H J T de Hingh, et al.
British Journal of Clinical Pharmacology|June 1, 2017
Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old womanCorine de Jong, Stefan Sanders, Geert-Jan Creemers, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2022
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?Emma C Hulshof, Mirjam de With, Geert-Jan Creemers, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic reviewRobin J Lurvink, Koen P Rovers, Simon W Nienhuijs, et al.
Gynecologic Oncology|February 8, 2011
Paraganglioma of the uterus. A case report and review of literatureJeanette van Leeuwen, Hans W H M van der Putten, Thomas B J Demeyere, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Drugs & Aging|March 17, 2007
First-line treatment strategies for elderly patients with metastatic colorectal cancerHielke J Meulenbeld, Geert-Jan Creemers
Case Reports in Oncology|November 29, 2018
Capecitabine-Associated Terminal IleitisIrene E G van Hellemond, Annemarie M Thijs, Geert-Jan Creemers
Clinical Colorectal Cancer|October 14, 2021
Standard-Dose Trifluridine/Tipiracil as Safe Treatment Alternative in Metastatic Colorectal Cancer Patients With DPD DeficiencyJeroen F Schouten, Jeroen Willems, Stefan J W J Sanders, et al.
United European Gastroenterology Journal|December 17, 2019
Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practiceLaura M Legué, Nienke Bernards, Valery Epp Lemmens, et al.
Journal of Palliative Medicine|February 27, 2013
Information provision and patient reported outcomes in patients with metastasized colorectal cancer: results from the PROFILES registryOlga Husson, Melissa S Y Thong, Floortje Mols, et al.
Clinical Colorectal Cancer|January 7, 2019
Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma PeritoneiLaura M Legué, Geert-Jan Creemers, Ignace H J T de Hingh, et al.
British Journal of Clinical Pharmacology|June 1, 2017
Pharmacogenetic analysis of irreversible severe cisplatin-induced nephropathy: a case report of a 27-year-old womanCorine de Jong, Stefan Sanders, Geert-Jan Creemers, et al.
European Journal of Cancer (Oxford, England : 1990)|July 6, 2022
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?Emma C Hulshof, Mirjam de With, Geert-Jan Creemers, et al.
Journal of Gastrointestinal Oncology|May 10, 2021
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic reviewRobin J Lurvink, Koen P Rovers, Simon W Nienhuijs, et al.
Gynecologic Oncology|February 8, 2011
Paraganglioma of the uterus. A case report and review of literatureJeanette van Leeuwen, Hans W H M van der Putten, Thomas B J Demeyere, et al.
Pageof 10